Schlaphoff, Verena

Publishing since 2007 (Baby)

Has published 12 publications in 4 years

Number of publications published per year by Schlaphoff, Verena. (Source : PubMed)

Distribution of publications types for Schlaphoff, Verena. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Stegmann KA, Björkström NK, Liermann H, Ciesek S, Riese P, Wiegand J, Hadem J, Suneetha PV, Jaroszewicz J, Wang C, Schlaphoff V, Fytili P, Cornberg M, Manns MP, Geffers R, Pietschmann T, Guzmán CA, Ljunggren HG, Wedemeyer H. Interferon-Alfa-Induced Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection.  Gastroenterology  2010  
•  Jirmo AC, Koya RC, Sundarasetty BS, Pincha M, Yu GY, Lai M, Bakshi R, Schlaphoff V, Grabowski J, Behrens G, Wedemeyer H, Stripecke R. Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.  Vaccine  2010;28;4  
•  Wang C, Heim A, Schlaphoff V, Suneetha PV, Stegmann KA, Jiang H, Krueger M, Fytili P, Schulz T, Cornberg M, Kandolf R, Manns MP, Bock CT, Wedemeyer H. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.  J. Med. Virol.  2009;81;12  
•  Wiegand J, Meya S, Schlaphoff V, Manns MP, Mössner J, Wedemeyer H, Tillmann HL. HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.  J. Viral Hepat.  2009  
•  Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.  Liver Int.  2009  
•  Wedemeyer H, Schuller E, Schlaphoff V, Stauber RE, Wiegand J, Schiefke I, Firbas C, Jilma B, Thursz M, Zeuzem S, Hofmann WP, Hinrichsen H, Tauber E, Manns MP, Klade CS. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.  Vaccine  2009;27;37  
•  Ghosh A, Koestner W, Hapke M, Schlaphoff V, Länger F, Baumann R, Koenecke C, Cornberg M, Welte K, Blazar BR, Sauer MG. Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras.  Blood  2009;113;18  
•  Deterding K, Pothakamuri SV, Schlaphoff V, Hadem J, Metzler F, Bahr MJ, Manns MP, Cornberg M, Wedemeyer H. Clearance of chronic HCV infection during acute delta hepatitis.  Infection  2009;37;2  
•  Suneetha PV, Schlaphoff V, Wang C, Stegmann KA, Fytili P, Sarin SK, Manns MP, Cornberg M, Wedemeyer H. Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.  J. Immunol. Methods  2009;342;1-2  
•  Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, Zauner W, Zachou K, Berg T, Manns MP, Klade CS, Cornberg M, Wedemeyer H. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.  Vaccine  2008;26;31  

[ See timeline ] [ See all publications ]